|
Volumn 15, Issue 2, 2001, Pages 264-271
|
The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro
a a |
Author keywords
Bone marrow microenvironment; Multiple myeloma; Therapeutic response
|
Indexed keywords
CELL PROTEIN;
CYCLIN D2;
DEXAMETHASONE;
DOXORUBICIN;
GLUCOCORTICOID;
GROWTH FACTOR;
INTERLEUKIN 6;
MELPHALAN;
MONOCLONAL ANTIBODY;
PAMIDRONIC ACID;
PROTEIN BCL XL;
THALIDOMIDE;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
BIOACCUMULATION;
BONE MARROW;
CANCER CELL;
CANCER CELL CULTURE;
CANCER GROWTH;
CELL DIFFERENTIATION;
CELL GROWTH;
CELL INTERACTION;
CELL PROTECTION;
CELLULAR DISTRIBUTION;
CONTROLLED STUDY;
DRUG RESISTANCE;
ENVIRONMENT;
GENETICS;
HEMATOPOIETIC CELL;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MULTIPLE MYELOMA;
MUTATION;
MYELOMA CELL;
ONCOGENE N RAS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
STROMA;
STROMA CELL;
|
EID: 0035102346
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402022 Document Type: Article |
Times cited : (52)
|
References (33)
|